View drug registration information details.


ItemsRegistration information
ID390
No390
Brand NameDOBUTAMINE - HAMELN 12.5 MG/ML INJECTION
IngredientsDOBUTAMINE HYDROCHLORIDE 14 MG/ML EQ.TO DOBUTAMINE 12.5 MG/ML
Dosage FormSOLUTION FOR INJECTION
Primary PackagingAMPOULES
StorageDO NOT STORE 25"C
Shelf Life36 MONTHS FROM MANUFACTURING DATE
Pack SizeBOX OF 5 AMPOULES X 20 ML
Dispensing CategoryPrescription only
ATC ClassificationC01CA07
Pharmaceutical ClassDOPAMINERGIC AGENT
IndicationsDOBUTAMINE IS INDICATED FOR PATIENTS WHO REQUIRE A POSITIVE INOTROPIC SUPPORT IN THE TREATMENT OF CARDIAC DECOMPENSATION DUE TO DEPRESSED CONTRACTILITY.IN CARDIOGENIC SHOCK CHARACTERISED BY HEART FAILURE WITH SEVERE HYPOTENSION.
ContraindicationsDOBUTAMINE MUST NOT BE USED IN THE CASE OF : - KNOWN HYPERSENSITIVITY TO DOBUTAMINE OR TO ANY OF THE EXCIPIENTS
Side EffectsEVALUATION OF UNDESIRABLE EFFECTS IS BASED ON THE FOLLOWING FREQUENCY SCALE : CARDIOVASCULAR.
Unit Price-
EDL Yes
DescriptionTHE PRODUCT IS A CLEAR, COLOURLESS OR ALMOST COLOURLESS SOLUTION
Note
License OwnerDAOVI PHARMA IMPORT-EXPORT SOLE CO.,LTD
ManufacturerSIEGFRIED HAMELN GMBH
CountryGERMANY
Import Registration No51613.01.00
Import Registration Date2004-04-23
ActivityCERTIFICATE RELEASED
Applied Date2021-08-19
FDD Registration No11 I 4335/17
FDD Registration Date2022-05-17
Expiry Date2025-05-16

Back to drug list